Biocept, Inc.
Biocept, Inc. (BIOCQ) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
biocq · pe ratio · data through Dec 31, 2022
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Biocept, Inc. (BIOCQ) measures how much investors pay for each dollar of the company's trailing earnings. BIOCQ's current PE ratio of N/A is calculated by dividing its stock price of $0.00 by its TTM earnings per share of -$56.78.
Source: FMP · /ratios-ttm · /analyst-estimates · 2022-12-31
PE Ratio History
2019 – 2022 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
PE Ratio vs Peers
Medical - Diagnostics & Research · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Biocept, Inc.You BIOCQ | $0M | N/A | — | -$56.78 |
 Biostar Pharmaceuticals, Inc. BSPM | $0M | N/A | — | -$2.48 |
 BC Craft Supply Co. Ltd. CRFTF | $0M | N/A | — | -$0.96 |
 Plant-Based Investment Corp. CWWBF | $0M | N/A | — | -$0.23 |
 HTG Molecular Diagnostics, Inc. HTGMQ | $0M | N/A | — | -$24.28 |
 MedAvail Holdings, Inc. MDVLQ | $0M | N/A | — | -$36.20 |
 Nabriva Therapeutics plc NBRVF | $0M | N/A | — | -$21.32 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2022-12-31Latest FY2022 | — | $-56.78 | — | |
2021-12-31 FY2021 | — | $-5.73 | — | |
2020-12-31 FY2020 | — | $-45.10 | — | |
2019-12-31 FY2019 | — | $-365.01 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Biocept, Inc. (BIOCQ) measures how much investors pay for each dollar of the company's trailing earnings. BIOCQ's current PE ratio of N/A is calculated by dividing its stock price of $0.00 by its TTM earnings per share of -$56.78.
Frequently asked questions
BIOCQ pe ratio · 6 questionsBIOCQ's current PE ratio is N/A as of 2026-06-09, based on a stock price of $0.00 and TTM EPS of -$56.78. Data sourced from Financial Modeling Prep via BIOCQ's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Biocept, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09